Alnylam Pharmaceuticals (ALNY) shares outstanding: 133.9M
Alnylam Pharmaceuticals had 133.9M shares outstanding on Oct 23, 2026, up 1.4% from 132.1M a year earlier.
From Alnylam Pharmaceuticals's filings with the SEC · ALNY stock page
Alnylam Pharmaceuticals shares outstanding by year
#1,003 of 3,715 US companies by shares outstanding · See the full ranking
| Year ended | Shares outstanding | Change |
|---|---|---|
| Oct 23, 2026 | 133.9M | +1% |
| Oct 24, 2025 | 132.1M | +2% |
| Oct 25, 2024 | 129.0M | +3% |
| Oct 27, 2023 | 125.5M | +2% |
| Oct 21, 2022 | 123.0M | – |
Shares outstanding of similar companies
Companies in the same industry as Alnylam Pharmaceuticals, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.
| Company | Shares outstanding, latest year | Year ended |
|---|---|---|
| Arrowhead Pharmaceuticals | 141.4M | Nov 5, 2026 |
| Cytokinetics | 139.3M | Nov 2, 2026 |
| PERRIGO | 138.8M | Oct 30, 2026 |
| Aurinia Pharmaceuticals | 134.0M | Oct 29, 2026 |
| Alnylam Pharmaceuticals | 133.9M | Oct 23, 2026 |
| Amylyx Pharmaceuticals | 128.6M | Oct 26, 2026 |
| Viking Therapeutics | 127.5M | Oct 15, 2026 |
Questions and answers
What is Alnylam Pharmaceuticals's shares outstanding?
Alnylam Pharmaceuticals had 133.9M shares outstanding on Oct 23, 2026, up 1.4% from 132.1M a year earlier.
Numbers as reported in Alnylam Pharmaceuticals's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology